Sandbox:algorthim: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 23: Line 23:
'''[[Rituximab]] {{and}} chlorambucil'''</div>|E02=<div style="width: 13em; padding:1em;">'''FISH chromosomal analysis'''</div>}}
'''[[Rituximab]] {{and}} chlorambucil'''</div>|E02=<div style="width: 13em; padding:1em;">'''FISH chromosomal analysis'''</div>}}
{{familytree | | | | | | | |!| | | | | | | | | | | | | | | }}
{{familytree | | | | | | | |!| | | | | | | | | | | | | | | }}
{{familytree | |,|-|-|-|+|-|-|-|.| | | | | | | | | | | | | }}
{{familytree | | | |,|-|-|-|+|-|-|-|.| | | | | | | | | | | | | }}
{{familytree | G01 | | G02 | | G03 | | | | | | | | | | | | |G01=<div style="width: 13em; padding:1em;">'''Immunochemotherapeutic regimens for the management of patients without chromosome 17p deletion or chromosome 11q deletion can be found [[#Immunochemotherapeutic Regimens for the Management of Patients without Chromosome 17p Deletion or Chromosome 11q Deletion|'''here''']]'''</div>|G02=<div style="width: 15em; padding:1em;">'''Immunochemotherapeutic regimens for the management of patients with chromosome 17p deletion can be found [[#Immunochemotherapeutic Regimens for the Management of Patients with Chromosome 17p Deletion|'''here''']]'''</div>|G03=<div style="width: 15em; padding:1em;">'''Immunochemotherapeutic regimens for the management of patients with chromosome 11q deletion can be found [[#Immunochemotherapeutic Regimens for the Management of Patients with Chromosome 11q Deletion|'''here''']]'''</div>}}
{{familytree | | | G01 | | G02 | | G03 | | | | | | | | | | | | |G01=<div style="width: 13em; padding:1em;">'''Immunochemotherapeutic regimens for the management of patients without chromosome 17p deletion or chromosome 11q deletion can be found [[#Immunochemotherapeutic Regimens for the Management of Patients without Chromosome 17p Deletion or Chromosome 11q Deletion|'''here''']]'''</div>|G02=<div style="width: 15em; padding:1em;">'''Immunochemotherapeutic regimens for the management of patients with chromosome 17p deletion can be found [[#Immunochemotherapeutic Regimens for the Management of Patients with Chromosome 17p Deletion|'''here''']]'''</div>|G03=<div style="width: 15em; padding:1em;">'''Immunochemotherapeutic regimens for the management of patients with chromosome 11q deletion can be found [[#Immunochemotherapeutic Regimens for the Management of Patients with Chromosome 11q Deletion|'''here''']]'''</div>}}
{{familytree/end}}
{{familytree/end}}

Latest revision as of 11:38, 27 October 2015

 
 
 
 
 
Initial patients evaluation
 
 
 
 
 
 
 
 
 
 
History
Physical examination
Complete blood count
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Staging
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rai Staging System
Binet Staging System
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rai stage 0-2
Binet stage A
 
 
 
Rai stage 3-4
Binet stage B-C
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients managed by observation and close follow-up
 
 
 
Evaluate patients by Cumulative Index Illness Rating Scale
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fit patients (CIRS <6)
 
Frail patients (CIRS ≥6)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FISH chromosomal analysis
 

Obinutuzumab AND chlorambucil
Ofatumumab AND chlorambucil

Rituximab AND chlorambucil
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Immunochemotherapeutic regimens for the management of patients without chromosome 17p deletion or chromosome 11q deletion can be found here
 
Immunochemotherapeutic regimens for the management of patients with chromosome 17p deletion can be found here
 
Immunochemotherapeutic regimens for the management of patients with chromosome 11q deletion can be found here